Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.28298 | 69 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.14823 | 49 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.35702 | 55 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.04893 | 47 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.44595 | 58 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.46582 | 55 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.59303 | 58 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.19274 | 50 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.27058 | 53 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.20593 | 51 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.3049 | 53 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.27401 | 53 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.31164 | 53 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.31059 | 53 |